Performance of serum amyloid A and C reactive protein for disease control assessment in familial Mediterranean fever
The Journal of Allergy and Clinical Immunology: In Practice · 2025-01 · 13 (1) · 233-235.e2
DOI: 10.1016/j.jaip.2024.09.035 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2025-01. Verfasst von Inès Elhani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Pediatrics, Versailles Hospital, Versailles, France; National French Reference Centre for Auto-inflammatory Diseases and Inflam…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Familial Mediterranean fever (FMF) is a monogenic autoinflammatory disease responsible for periodic inflammatory flares. The most critical complication of FMF is AA amyloidosis.1 It is caused by the deposition of serum amyloid A (SAA) proteins in the organs due to repeated or chronic high levels of SAA.2 European recommendations for the treatment of FMF suggest that C-reactive protein (CRP) and SAA levels should be monitored.2,3 The assessment of disease control relies on both inflammatory markers and declared number of flares, which can be subjective.
Autor:innen und Institutionen
- Department of General Pediatrics, Versailles Hospital, Versailles, France; National French Reference Centre for Auto-inflammatory Diseases and Inflammatory Amyloidosis (CEREMAIA), Paris, France; Department of Internal M…
- Department of General Pediatrics, Versailles Hospital, Versailles, France; National French Reference Centre for Auto-inflammatory Diseases and Inflammatory Amyloidosis (CEREMAIA), Paris, France; Pediatric Nephrology, Rh…
- Laboratory of Rheumatology, GIGA Research, CHU Liège, ULiege, Liège, Belgium.
- Department of General Pediatrics, Versailles Hospital, Versailles, France; National French Reference Centre for Auto-inflammatory Diseases and Inflammatory Amyloidosis (CEREMAIA), Paris, France.
- CIRI, Centre International de Recherche en Infectiologie/International Center for Infectiology Research, Inserm, U1111, Ecole Normale Supérieure de Lyon, Université Lyon 1, CNRS, UMR5308, Lyon, France.
- National French Reference Centre for Auto-inflammatory Diseases and Inflammatory Amyloidosis (CEREMAIA), Paris, France; Pediatric Nephrology, Rheumatology, Dermatology Unit, National Referee Centre for Rheumatic and Aut…
Zitieren
APA
Elhani, I., Jouret, M., Malaise, O., Nguyen, A. T., Sarda, M. N., Belot, A., & Hentgen, V. (2025). Performance of serum amyloid A and C reactive protein for disease control assessment in familial Mediterranean fever. The Journal of Allergy and Clinical Immunology: In Practice, 13(1), 233-235.e2. https://doi.org/10.1016/j.jaip.2024.09.035
Vancouver
Elhani I, Jouret M, Malaise O, Nguyen AT, Sarda MN, Belot A, et al. Performance of serum amyloid A and C reactive protein for disease control assessment in familial Mediterranean fever. The Journal of Allergy and Clinical Immunology: In Practice. 2025;13(1):233-235.e2. doi:10.1016/j.jaip.2024.09.035
BibTeX
@article{Elhani2025,
author = {Elhani, Inès and Jouret, Maurine and Malaise, Olivier and Nguyen, Ai-Tien and Sarda, Marie-Nathalie and Belot, Alexandre and Hentgen, Véronique},
title = {Performance of serum amyloid A and C reactive protein for disease control assessment in familial Mediterranean fever},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
year = {2025},
volume = {13},
number = {1},
pages = {233--235.e2},
doi = {10.1016/j.jaip.2024.09.035}
}
EUVIMED